Showing results (141-150 of 339) with videos related to
Sort By:
Pageof 34
Transfusion|November 9, 2002
Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donorsKaren K Ballen, Julie Hicks, Bernie Dharan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201Galen E Switzer, Jessica G Bruce, Donna Harrington, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2010
The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantationElizabeth A Murphy, Stacy Stickney Ferguson, Nancy Atieno Omondi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantationMichael A Andrykowski, Michelle M Bishop, Elizabeth A Hahn, et al.Journal of Clinical Microbiology|April 13, 2007
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipientsCornelius J Clancy, Reia A Jaber, Helen L Leather, et al.Cytotherapy|February 10, 2016
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cellsNancy Y Villa, Swarna Bais, Winnie M Chan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of americaAlison G Freifeld, Eric J Bow, Kent A Sepkowitz, et al.Annals of Internal Medicine|January 7, 2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialMichael Boeckh, W Garrett Nichols, Roy F Chemaly, et al.Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.Pageof 34